KRISTEN MARINO: Open Payments
NPI 1114534971 · CREVE COEUR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 32 payments from 10 companies in 2025. Trend: 2023 $147 · 2024 $1,366 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $363 |
| GENZYME CORPORATION | 6 | $192 |
| Novartis Pharmaceuticals Corporation | 2 | $141 |
| Organon LLC | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| CSL Behring | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Grifols USA, LLC | 2 | $45 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| BioCryst US Sales Co., LLC | 1 | $23 |
Products named: DUPIXENT, FASENRA, VTAMA, Hizentra, TEZSPIRE, AIRSUPRA, CUVITRU, HYQVIA.
Industry payments across MO — which companies pay providers there.
